| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $65.7M | -23.3% |
| SG&A Expense | $23.4M | -11.9% |
| Operating Income | -$90.6M | +18.7% |
| Income Tax | $0 | — |
| Net Income | -$83.7M | +17.8% |
| EPS (Basic) | -$11.49 | -720.7% |
| EPS (Diluted) | -$11.49 | -720.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $41.7M | +17.6% |
| Short-term Investments | $90.5M | -45.4% |
| Current Assets | $137.5M | -33.6% |
| Total Assets | $144.7M | -34.6% |
| Current Liabilities | $20.3M | +14.6% |
| Long-term Debt | $5.1M | -48.9% |
| Total Liabilities | $27.8M | -17.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$74.2M | +9.1% |
| Capital Expenditures | $29K | -98.4% |
| Investing Cash Flow | $80.4M | +5.8% |
| Financing Cash Flow | $103K | -83.9% |
| Free Cash Flow | -$74.2M | +11.0% |
| Stockholders' Equity |
| $116.9M |
| -37.7% |